List of Tables
Table 1. Global PEGylated Granulocyte-Colony Stimulating Factor Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global PEGylated Granulocyte-Colony Stimulating Factor Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global PEGylated Granulocyte-Colony Stimulating Factor Market Competitive Situation by Manufacturers in 2025
Table 4. Global PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Manufacturers (2021–2026)
Table 6. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market PEGylated Granulocyte-Colony Stimulating Factor Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of PEGylated Granulocyte-Colony Stimulating Factor, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of PEGylated Granulocyte-Colony Stimulating Factor, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of PEGylated Granulocyte-Colony Stimulating Factor, Product Types and Applications
Table 12. Global Key Manufacturers of PEGylated Granulocyte-Colony Stimulating Factor, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PEGylated Granulocyte-Colony Stimulating Factor Companies by Tier (Tier 1, Tier 2, Tier 3), based on PEGylated Granulocyte-Colony Stimulating Factor Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PEGylated Granulocyte-Colony Stimulating Factor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global PEGylated Granulocyte-Colony Stimulating Factor Sales by Region (K Units), 2021–2026
Table 18. Global PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Region (2021–2026)
Table 19. Global PEGylated Granulocyte-Colony Stimulating Factor Sales by Region (K Units), 2027–2032
Table 20. Global PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Region (2027–2032)
Table 21. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue by Region (US$ Million), 2021–2026
Table 22. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Region (2021–2026)
Table 23. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue by Region (US$ Million), 2027–2032
Table 24. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Region (2027–2032)
Table 25. North America PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America PEGylated Granulocyte-Colony Stimulating Factor Sales by Country (K Units), 2021–2026
Table 27. North America PEGylated Granulocyte-Colony Stimulating Factor Sales by Country (K Units), 2027–2032
Table 28. North America PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country (US$ Million), 2021–2026
Table 29. North America PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country (US$ Million), 2027–2032
Table 30. Europe PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe PEGylated Granulocyte-Colony Stimulating Factor Sales by Country (K Units), 2021–2026
Table 32. Europe PEGylated Granulocyte-Colony Stimulating Factor Sales by Country (K Units), 2027–2032
Table 33. Europe PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country (US$ Million), 2021–2026
Table 34. Europe PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific PEGylated Granulocyte-Colony Stimulating Factor Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific PEGylated Granulocyte-Colony Stimulating Factor Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific PEGylated Granulocyte-Colony Stimulating Factor Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific PEGylated Granulocyte-Colony Stimulating Factor Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific PEGylated Granulocyte-Colony Stimulating Factor Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America PEGylated Granulocyte-Colony Stimulating Factor Sales by Country (K Units), 2021–2026
Table 42. Latin America PEGylated Granulocyte-Colony Stimulating Factor Sales by Country (K Units), 2027–2032
Table 43. Latin America PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa PEGylated Granulocyte-Colony Stimulating Factor Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa PEGylated Granulocyte-Colony Stimulating Factor Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa PEGylated Granulocyte-Colony Stimulating Factor Revenue by Country (US$ Million), 2027–2032
Table 50. Global PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units) by Type (2021–2026)
Table 51. Global PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units) by Type (2027–2032)
Table 52. Global PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2021–2026)
Table 53. Global PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2027–2032)
Table 54. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue (US$ Million) by Type (2021–2026)
Table 55. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue (US$ Million) by Type (2027–2032)
Table 56. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Type (2021–2026)
Table 57. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Type (2027–2032)
Table 58. Global PEGylated Granulocyte-Colony Stimulating Factor Price (US$/Unit) by Type (2021–2026)
Table 59. Global PEGylated Granulocyte-Colony Stimulating Factor Price (US$/Unit) by Type (2027–2032)
Table 60. Global PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units) by Application (2021–2026)
Table 61. Global PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units) by Application (2027–2032)
Table 62. Global PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2021–2026)
Table 63. Global PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2027–2032)
Table 64. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue (US$ Million) by Application (2021–2026)
Table 65. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue (US$ Million) by Application (2027–2032)
Table 66. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Application (2021–2026)
Table 67. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Application (2027–2032)
Table 68. Global PEGylated Granulocyte-Colony Stimulating Factor Price (US$/Unit) by Application (2021–2026)
Table 69. Global PEGylated Granulocyte-Colony Stimulating Factor Price (US$/Unit) by Application (2027–2032)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Amgen PEGylated Granulocyte-Colony Stimulating Factor Product
Table 74. Amgen Recent Developments/Updates
Table 75. Mylan Company Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Mylan PEGylated Granulocyte-Colony Stimulating Factor Product
Table 79. Mylan Recent Developments/Updates
Table 80. Kashiv BioSciences Company Information
Table 81. Kashiv BioSciences Description and Business Overview
Table 82. Kashiv BioSciences PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Kashiv BioSciences PEGylated Granulocyte-Colony Stimulating Factor Product
Table 84. Kashiv BioSciences Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Pfizer PEGylated Granulocyte-Colony Stimulating Factor Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Fresenius Kabi Company Information
Table 91. Fresenius Kabi Description and Business Overview
Table 92. Fresenius Kabi PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Fresenius Kabi PEGylated Granulocyte-Colony Stimulating Factor Product
Table 94. Fresenius Kabi Recent Developments/Updates
Table 95. Coherus BioSciences Company Information
Table 96. Coherus BioSciences Description and Business Overview
Table 97. Coherus BioSciences PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Coherus BioSciences PEGylated Granulocyte-Colony Stimulating Factor Product
Table 99. Coherus BioSciences Recent Developments/Updates
Table 100. Sandoz Company Information
Table 101. Sandoz Description and Business Overview
Table 102. Sandoz PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sandoz PEGylated Granulocyte-Colony Stimulating Factor Product
Table 104. Sandoz Recent Developments/Updates
Table 105. Jiangsu Hengrui Pharmaceuticals Company Information
Table 106. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 107. Jiangsu Hengrui Pharmaceuticals PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Jiangsu Hengrui Pharmaceuticals PEGylated Granulocyte-Colony Stimulating Factor Product
Table 109. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 110. Amoytop Biotech Company Information
Table 111. Amoytop Biotech Description and Business Overview
Table 112. Amoytop Biotech PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Amoytop Biotech PEGylated Granulocyte-Colony Stimulating Factor Product
Table 114. Amoytop Biotech Recent Developments/Updates
Table 115. Qilu Pharmaceutical Company Information
Table 116. Qilu Pharmaceutical Description and Business Overview
Table 117. Qilu Pharmaceutical PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Qilu Pharmaceutical PEGylated Granulocyte-Colony Stimulating Factor Product
Table 119. Qilu Pharmaceutical Recent Developments/Updates
Table 120. CSPC Baike Biopharma Company Information
Table 121. CSPC Baike Biopharma Description and Business Overview
Table 122. CSPC Baike Biopharma PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. CSPC Baike Biopharma PEGylated Granulocyte-Colony Stimulating Factor Product
Table 124. CSPC Baike Biopharma Recent Developments/Updates
Table 125. SL Pharm Company Information
Table 126. SL Pharm Description and Business Overview
Table 127. SL Pharm PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. SL Pharm PEGylated Granulocyte-Colony Stimulating Factor Product
Table 129. SL Pharm Recent Developments/Updates
Table 130. Lunan Pharmaceutical Company Information
Table 131. Lunan Pharmaceutical Description and Business Overview
Table 132. Lunan Pharmaceutical PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Lunan Pharmaceutical PEGylated Granulocyte-Colony Stimulating Factor Product
Table 134. Lunan Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. PEGylated Granulocyte-Colony Stimulating Factor Distributors List
Table 138. PEGylated Granulocyte-Colony Stimulating Factor Customers List
Table 139. PEGylated Granulocyte-Colony Stimulating Factor Market Trends
Table 140. PEGylated Granulocyte-Colony Stimulating Factor Market Drivers
Table 141. PEGylated Granulocyte-Colony Stimulating Factor Market Challenges
Table 142. PEGylated Granulocyte-Colony Stimulating Factor Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of PEGylated Granulocyte-Colony Stimulating Factor
Figure 2. Global PEGylated Granulocyte-Colony Stimulating Factor Market Value by Type (US$ Million), 2021–2032
Figure 3. Global PEGylated Granulocyte-Colony Stimulating Factor Market Share by Type: 2025 & 2032
Figure 4. Pegfilgrastim Product Picture
Figure 5. Mecapegfilgrastim Product Picture
Figure 6. Telpegfilgrastim Product Picture
Figure 7. Other Product Picture
Figure 8. Global PEGylated Granulocyte-Colony Stimulating Factor Market Value by Application (US$ Million), 2021–2032
Figure 9. Global PEGylated Granulocyte-Colony Stimulating Factor Market Share by Application: 2025 & 2032
Figure 10. Hospital and Clinic
Figure 11. Pharmacy
Figure 12. Other
Figure 13. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global PEGylated Granulocyte-Colony Stimulating Factor Market Size (US$ Million), 2021–2032
Figure 15. Global PEGylated Granulocyte-Colony Stimulating Factor Sales (K Units), 2021–2032
Figure 16. Global PEGylated Granulocyte-Colony Stimulating Factor Average Price (US$/Unit), 2021–2032
Figure 17. PEGylated Granulocyte-Colony Stimulating Factor Report Years Considered
Figure 18. PEGylated Granulocyte-Colony Stimulating Factor Sales Share by Manufacturers in 2025
Figure 19. Global PEGylated Granulocyte-Colony Stimulating Factor Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global PEGylated Granulocyte-Colony Stimulating Factor Players: Market Share by Revenue in PEGylated Granulocyte-Colony Stimulating Factor in 2025
Figure 21. PEGylated Granulocyte-Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global PEGylated Granulocyte-Colony Stimulating Factor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Country (2021–2032)
Figure 24. North America PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Country (2021–2032)
Figure 25. United States PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Country (2021–2032)
Figure 28. Europe PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Country (2021–2032)
Figure 29. Germany PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Region (2021–2032)
Figure 36. China PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Country (2021–2032)
Figure 44. Latin America PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Country (2021–2032)
Figure 45. Mexico PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa PEGylated Granulocyte-Colony Stimulating Factor Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa PEGylated Granulocyte-Colony Stimulating Factor Revenue Market Share by Country (2021–2032)
Figure 51. Turkey PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE PEGylated Granulocyte-Colony Stimulating Factor Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of PEGylated Granulocyte-Colony Stimulating Factor by Type (2021–2032)
Figure 55. Global Revenue Market Share of PEGylated Granulocyte-Colony Stimulating Factor by Type (2021–2032)
Figure 56. Global PEGylated Granulocyte-Colony Stimulating Factor Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of PEGylated Granulocyte-Colony Stimulating Factor by Application (2021–2032)
Figure 58. Global Revenue Market Share of PEGylated Granulocyte-Colony Stimulating Factor by Application (2021–2032)
Figure 59. Global PEGylated Granulocyte-Colony Stimulating Factor Price (US$/Unit) by Application (2021–2032)
Figure 60. PEGylated Granulocyte-Colony Stimulating Factor Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
